Our business is split into three core areas. Generic Drug Substances (GDS) is still the heartland for many of our customers. Custom Manufacturing Solutions (CMS) is now nearly as large and is the fastest growing part of our business. Peptides is an expression of our expertise in a certain aspect of chemistry.
Neuland is at the forefront of facilitating and accelerating drug development and cGMP manufacturing of APIs. The Company’s technical and scientific teams provide reliable solutions and services to the global pharmaceutical industry.
Neuland follows a strong set of ethical values, termed ‘The Neuland Way’, that spurs integrity and motivation among the work force. The Neuland Way is made up of five defined values: Customer Centricity; Reliability; Accountability; Ownership; Openness & Transparency; and the core of Neuland’s business is built upon these values.
Neuland launches a new e-book. The collection of articles in this e-book discusses some of the key factors driving the pharmaceutical API industry.
Neuland is attending CPHI Frankfurt 2022. Meet us at Stand No: D60, Hall: 11, Messe Frankfurt, Germany.
To know more about the event and to get in touch with our team of experts, Click here.
Putting Customers First: Customer Centricity in Pharma API Manufacturing
Posted on January 1, 2023 by Saharsh Davuluri
Customer centricity is central to every organization and an important strategic priority for B2B companies. While there are many definitions of customer centricity, the ultimate objective of a customer-centric organization…
Neuland is committed to its stakeholders for their sustainable and long-term enrichment. Investor Relations is a top priority and we aim to meet all expectations with timely and reliable information.
Neuland facilitates accelerated career growth for self-driven and motivated professionals who are willing to learn, explore and flourish with the company. If you would like to make a career with us in R&D, manufacturing, engineering, sales and marketing, finance, or supply chain management then we’d like to hear from you.